![Peter DiRoma](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter DiRoma
Consejero General en
RA PHARMACEUTICALS, INC.
.
Perfil
Peter DiRoma is a professional with experience in regulatory affairs and quality assurance.
He is currently the Senior VP-Regulatory, Quality & Government Affairs at Ra Pharmaceuticals, Inc. Prior to this, he held positions as Vice President-Regulatory Affairs at Merck KGaA, EMD Serono, Inc., and Vice President-Global Regulatory Affairs at Dendreon Corp.
He also served as Senior VP-Regulatory Affairs & Quality Assurance at Melinta Therapeutics, Inc. and VP-Regulatory Affairs & Quality Assurance at Melinta Subsidiary Corp.
Mr. DiRoma received his undergraduate degree from the University of South Florida.
Cargos activos de Peter DiRoma
| Empresas | Cargo | Inicio |
|---|---|---|
| RA PHARMACEUTICALS, INC. | Consejero General | 01/11/2018 |
Antiguos cargos conocidos de Peter DiRoma.
| Empresas | Cargo | Fin |
|---|---|---|
| MELINTA THERAPEUTICS, INC. | Consejero General | 01/09/2018 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Consejero General | - |
| MERCK KGAA | Consejero General | - |
| DENDREON CORPORATION | Consejero General | - |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Consejero General | - |
Formación de Peter DiRoma.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
12
Relaciones de 1er grado
7
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses | Health Technology |
- Bolsa de valores
- Insiders
- Peter DiRoma
